Kursprognose für Evommune Inc (EVMN)EVMNEvommune Inc

Alphio's EVMN stock price prediction model matches the current Evommune Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.89 (-0.94%). The 1-week path is $12.27 (+2.25%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Evommune, Inc. is currently trading at $13.23, significantly below analyst price targets of $28 and $29, indicating potential upside of over 110%. However, the stock is under pressure due to disappointing trial results, with a recent 31% drop after a failed Phase 2b trial. The RSI is at 37.82, suggesting the stock is not yet in a strong buying position. Given these factors, while there is potential for recovery, the risks associated with its recent performance and ongoing trials warrant a hold recommendation for now.

Evommune Inc (EVMN) last closed at $12, losing -3.85%. These facts feed the 1-day and 1-week EVMN price prediction above.